FIG
BIOSW

Fortress Investment Group’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Fortress Investment Group’s Portfolio BIOSW Stock Details BIOSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-92,649
Closed -$9.26K – 94
2022
Q4 		$9.26K Hold
92,649
– – ﹤0.01% 52
2022
Q3 		$8K Hold
92,649
– – ﹤0.01% 90
2022
Q2 		$13K Hold
92,649
– – ﹤0.01% 104
2022
Q1 		$21K Buy
+92,649
New +$24.1K ﹤0.01% 151

Other funds holding BIOSW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fortress Investment Group's BIOSW Position: Q1 2023 in Review

Fortress Investment Group sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q1 2023, closing a stake of 92,649 shares — an estimated $9.26K sold.

Fortress Investment Group first reported a position in BIOSW in Q1 2022 and held it in 4 quarters. The position peaked at $21K in Q1 2022. 43 funds tracked by Wall St. Rank hold BIOSW as of Q1 2023.

  • Fortress Investment Group reported no remaining BioPlus Acquisition Corp. Warrants position as of Q1 2023 after selling out during the quarter.
  • Fortress Investment Group sold 92,649 BioPlus Acquisition Corp. Warrants shares in Q1 2023, an estimated $9.26K.
  • Fortress Investment Group first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 4 quarters.
  • Fortress Investment Group's BioPlus Acquisition Corp. Warrants position peaked at $21K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q1 2023.

Based on Fortress Investment Group's 13F filing for Q1 2023, filed 15 May 2023.